PBS NewsHour | A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it? PBS NewsHour A drug succeeded in lowering cardiovascular risks in a clinical trial, but questions remain over whether insurers will cover it. Photo by RunPhoto via Getty Images. A cholesterol-cutting drug from Amgen succeeded in lowering patients' risk of … Cholesterol drug prevents heart attacks — at $14000 a year Cholesterol drug cuts heart risks, spurs new debate on cost Cholesterol-slashing drug does not impair brain: study |
A pricey drug cuts cardiovascular risks in clinical trial — but will insurers cover it? – PBS NewsHour added by admin on
View all posts by admin →
You must be logged in to post a comment Login